Abstract
The objective of this study was to determine the predictive value of serum fatty acid binding protein 4 (FABP4) combined with Doppler of the uterine artery in singleton pregnancy at gestational age (GA) 11–13+6 weeks for prediction of preeclampsia. A prospective observational study included singleton pregnant women at GA 11–13+6 weeks and was conducted at the Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand, between December 2020 and April 2022. Serum FABP4 levels and Doppler of the uterine artery were performed. Pregnancy outcomes were recorded. The predictive values of these combined tests at the optimal cut-off values were determined to predict preeclampsia. A total of 330 participants with 15 cases of preeclampsia (4.5%) and 6 cases of them had preterm preeclampsia (GA < 37 weeks) (1.8%) were analyzed. Women with preeclampsia had significantly higher serum FABP4 levels than normal pregnant women (12.9 ± 6.5 ng/ml vs 10.1 ± 4.8 ng/ml, p = 0.034) but no difference in the mean pulsatility index (PI) of the uterine artery and the presence of an early diastolic notch. When using serum FABP4 levels greater than 1.0 multiple of the median of GA as a cut-off value to predict preeclampsia, combined with abnormal Doppler PI of the uterine artery, the sensitivity, specificity, positive predictive value, and negative predictive value were 73.3%, 47.3%, 6.2%, and 97.4%, respectively. This study demonstrated that serum FABP4 levels combined with Doppler of the uterine artery at GA 11–13+6 weeks were effective in predicting preeclampsia.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367:1066–74.
Maternal and Child Health Group, Bureau of Health Promotion. Department of Health. Statistical report of maternal deaths. Thailand; 2018.
Abalos E, Cuesta C, Grosso AL, Chou D, Say L. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2013;170:1–7.
Mutter WP, Karumanchi SA. Molecular mechanisms of preeclampsia. Microvasc Res. 2008;75:1–8.
Gestational Hypertension and Preeclampsia. ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020;135:e237–60.
Kaya B, Nayki U, Nayki C, Ulug P, Oner G, Gultekin E, et al. Proliferation of trophoblasts and Ki67 expression in preeclampsia. Arch Gynecol Obstet. 2015;291:1041–6.
Roberts JM, Hubel CA. The two stage model of preeclampsia: variations on the theme. Placenta. 2009;30(Suppl A):S32–7.
Conde-Agudelo A, Villar J, Lindheimer M. World Health Organization systematic review of screening tests for preeclampsia. Obstet Gynecol. 2004;104:1367–91.
Onwudiwe N, Yu CKH, Poon LCY, Spiliopoulos I, Nicolaides KH. Prediction of pre-eclampsia by a combination of maternal history, uterine artery Doppler and mean arterial pressure. Ultrasound Obstet Gynecol. 2008;32:877–83.
Chaemsaithong P, Sahota DS, Poon LC. First trimester preeclampsia screening and prediction. Am J Obstet Gynecol. 2022;226:S1071–97.e2.
Furuhashi M, Saitoh S, Shimamoto K, Miura T. Fatty Acid-Binding Protein 4 (FABP4): pathophysiological insights and potent clinical biomarker of metabolic and cardiovascular diseases. Clin Med Insights Cardiol. 2015;8:23–33.
Jadoon A, Cunningham P, McDermott LC. Regulation of fatty acid binding proteins by hypoxia inducible factors 1a and 2a in the placenta: relevance to pre-eclampsia. Prostaglandins Leukot Ess Fat Acids. 2015;93:25–9.
Yan Y, Peng H, Wang P, Wang H, Dong M. Increased expression of fatty acid binding protein 4 in preeclamptic Placenta and its relevance to preeclampsia. Placenta. 2016;39:94–100.
Scifres CM, Catov JM, Simhan H. Maternal serum fatty acid binding protein 4 (FABP4) and the development of preeclampsia. J Clin Endocrinol Metab. 2012;97:E349–56.
Shi Y, Wang CC, Wu L, Zhang Y, Xu A, Wang Y. Pathophysiological insight into fatty acid-binding protein-4: multifaced roles in reproduction, pregnancy, and offspring health. Int J Mol Sci. 2023;24:12655.
Rolnik DL, Wright D, Poon LCY, Syngelaki A, O’Gorman N, de Paco Matallana C, et al. ASPRE trial: performance of screening for preterm pre-eclampsia. Ultrasound Obstet Gynecol. 2017;50:492–5.
Tianthong W, Phupong V. Serum hypoxia-inducible factor-1 alpha and uterine artery Doppler ultrasound during the first trimester for prediction of preeclampsia. Sci Rep. 2021;11:6674.
Siricharoenthai P, Phupong V. The first-trimester serum high-temperature requirement protease A4 and uterine artery Doppler for the prediction of preeclampsia. Sci Rep. 2023;13:8295.
Raybiotech. RayBio Human FABP4 ELISA Kit. United States of America; 2021.
Qiao GH, Sun XZ. Increased plasma fatty acid binding protein 4 concentration at the first prenatal visit and its relevance to preeclampsia. Hypertens Res. 2018;41:763–9.
Aksornphusitaphong A, Phupong V. Combination of serum histidine-rich glycoprotein and uterine artery Doppler to predict preeclampsia. Hypertens Res. 2018;41:275–81.
Prakansamut N, Phupong V. Serum SHARP1 and uterine artery Doppler for the prediction of preeclampsia. Sci Rep. 2019;9:12266.
Townsend R, Khalil A, Premakumar Y, Allotey J, Snell KIE, Chan C, et al. Prediction of pre-eclampsia: review of reviews. Ultrasound Obstet Gynecol. 2019;54:16–27.
US Preventive Services Task Force, Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, et al. Aspirin use to prevent preeclampsia and related morbidity and mortality: US Preventive Services Task Force Recommendation Statement. JAMA. 2021;326:1186–91.
Acknowledgements
We thank the staff and nurses of the Faculty of Medicine, Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Chulalongkorn University for their helpful suggestions and assistance. The authors thank Natnicha Houngham and Miss Walailak Thongthab for their technical assistance.
Funding
This study was supported by an internal research grant: Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University, study Grant number RA64/028 and Grant for International Research Integration: Research Pyramid, Ratchadaphiseksomphot Endowment Fund, Chulalongkorn University and Placental Related Disease Research Unit, Chulalongkorn University.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Paiboonborirak, C., Phupong, V. Serum fatty acid binding protein 4 and Doppler of uterine artery ultrasound in the first trimester for the prediction of preeclampsia. Hypertens Res 47, 1208–1215 (2024). https://doi.org/10.1038/s41440-023-01553-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41440-023-01553-y
Keywords
This article is cited by
-
Original article and review highlighted in this month of Hypertension Research
Hypertension Research (2024)